IBDEI0M6 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10119,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,10119,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,10119,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,10120,0)
 ;;=M34.1^^68^664^91
 ;;^UTILITY(U,$J,358.3,10120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10120,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,10120,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,10120,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,10121,0)
 ;;=M34.2^^68^664^273
 ;;^UTILITY(U,$J,358.3,10121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10121,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,10121,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,10121,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,10122,0)
 ;;=M34.81^^68^664^275
 ;;^UTILITY(U,$J,358.3,10122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10122,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,10122,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,10122,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,10123,0)
 ;;=M34.82^^68^664^276
 ;;^UTILITY(U,$J,358.3,10123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10123,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,10123,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,10123,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,10124,0)
 ;;=M34.83^^68^664^277
 ;;^UTILITY(U,$J,358.3,10124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10124,1,3,0)
 ;;=3^Systemic Sclerosis w/ Polyneuropathy
 ;;^UTILITY(U,$J,358.3,10124,1,4,0)
 ;;=4^M34.83
 ;;^UTILITY(U,$J,358.3,10124,2)
 ;;=^5011783
 ;;^UTILITY(U,$J,358.3,10125,0)
 ;;=M34.89^^68^664^274
 ;;^UTILITY(U,$J,358.3,10125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10125,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,10125,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,10125,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,10126,0)
 ;;=M34.9^^68^664^278
 ;;^UTILITY(U,$J,358.3,10126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10126,1,3,0)
 ;;=3^Systemic Sclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,10126,1,4,0)
 ;;=4^M34.9
 ;;^UTILITY(U,$J,358.3,10126,2)
 ;;=^5011785
 ;;^UTILITY(U,$J,358.3,10127,0)
 ;;=R21.^^68^664^257
 ;;^UTILITY(U,$J,358.3,10127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10127,1,3,0)
 ;;=3^Rash/Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,10127,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,10127,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,10128,0)
 ;;=R23.3^^68^664^269
 ;;^UTILITY(U,$J,358.3,10128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10128,1,3,0)
 ;;=3^Spontaneous Ecchymoses
 ;;^UTILITY(U,$J,358.3,10128,1,4,0)
 ;;=4^R23.3
 ;;^UTILITY(U,$J,358.3,10128,2)
 ;;=^5019295
 ;;^UTILITY(U,$J,358.3,10129,0)
 ;;=L03.113^^68^664^112
 ;;^UTILITY(U,$J,358.3,10129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10129,1,3,0)
 ;;=3^Cellulitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,10129,1,4,0)
 ;;=4^L03.113
 ;;^UTILITY(U,$J,358.3,10129,2)
 ;;=^5009033
 ;;^UTILITY(U,$J,358.3,10130,0)
 ;;=L03.114^^68^664^105
 ;;^UTILITY(U,$J,358.3,10130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10130,1,3,0)
 ;;=3^Cellulitis of Left Upper Limb
 ;;^UTILITY(U,$J,358.3,10130,1,4,0)
 ;;=4^L03.114
 ;;^UTILITY(U,$J,358.3,10130,2)
 ;;=^5009034
 ;;^UTILITY(U,$J,358.3,10131,0)
 ;;=L03.115^^68^664^109
 ;;^UTILITY(U,$J,358.3,10131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10131,1,3,0)
 ;;=3^Cellulitis of Right Lower Limb
 ;;^UTILITY(U,$J,358.3,10131,1,4,0)
 ;;=4^L03.115
 ;;^UTILITY(U,$J,358.3,10131,2)
 ;;=^5009035
 ;;^UTILITY(U,$J,358.3,10132,0)
 ;;=L03.116^^68^664^102
 ;;^UTILITY(U,$J,358.3,10132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10132,1,3,0)
 ;;=3^Cellulitis of Left Lower Limb
